Table 2.
Patient characteristics with esophageal adenocarcinomas (EAC) tumor staging according to the 8th edition of the TNM [30]. All cases were clinically assessed as cM0.
| ID | Max. Tumor Size (mm) | Grading [G1-G3] | T | N | No. of Lymph Nodes a | UICC |
|---|---|---|---|---|---|---|
| endoscopic resection (ESD) | ||||||
| E1 | 2.4 | 2 | 1a (m2) | cN0 | n.a. | IA |
| E2 | 3.7 | 2 | 1a (m2) | cN0 | n.a. | IA |
| E3 | 4.3 | 2 | 1a (m3) | cN0 | n.a. | IA |
| E4 | 5.1 | 1 | 1a (m2) | cN0 | n.a. | IA |
| E5 | 16.2 | 2 | 1a (m3) | cN0 | n.a. | IA |
| E6 | 8.1 | 1 | 1a (m2) | cN0 | n.a. | IA |
| E7 | 13.2 | 2 | 1a (m3) | cN0 | n.a. | IA |
| E8 | 8.3 | 2 | 1a (m2) | cN0 | n.a. | IA |
| E9 | 7.2 | 2 | 1a (m3) | cN0 | n.a. | IA |
| E10 | 5.1 | 1 | 1a (m1) | cN0 | n.a. | IA |
| esophagectomy (surgery) | ||||||
| R1 | 30 | 2 | 3 | 3 | 20/20 | IVA |
| R2 | 35 | 3 | 3 | 1 | 2/21 | IIIB |
| R3 | 20 | 2 | 3 | 2 | 8/55 | IIIB |
| R4 | 30 | 3 | 3 | 3 | 18/24 | IVA |
| R5 | 45 | 3 | 3 | 2 | 6/12 | IIIB |
| R6 | 28 | 2 | 3 | 2 | 4/12 | IIIB |
| R7 | 28 | 3 | 3 | 2 | 4/10 | IIIB |
| R8 | 76 | 2 | 3 | 2 | 6/49 | IIIB |
| R9 | 33 | 3 | 3 | 3 | 12/38 | IVA |
| R10 | 50 | 3 | 3 | 3 | 22/37 | IVA |
a The number indicates the number of lymph nodes resected during esophagectomy. Abbreviations: n.a. = not applicable, E = ESD-resected samples, R = surgically resected samples.